TM6SF2 and metabolic syndrome: Variants such as PNPLA3 and TM6SF2 have been associated with hepatic fat accumulation independent of metabolic syndrome, while lifestyle and environmental exposures—including diet composition, physical inactivity, and gut microbiome dysbiosis—may further influence disease expression [9, 10].